文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

利用全身炎症标志物预测肝细胞癌患者术前微血管侵犯

Using Systemic Inflammatory Markers to Predict Microvascular Invasion Before Surgery in Patients With Hepatocellular Carcinoma.

作者信息

Li Shumin, Zeng Qianwen, Liang Ruiming, Long Jianyan, Liu Yihao, Xiao Han, Sun Kaiyu

机构信息

Department of Gastroenterology and Hepatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Liver Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Front Surg. 2022 Mar 4;9:833779. doi: 10.3389/fsurg.2022.833779. eCollection 2022.


DOI:10.3389/fsurg.2022.833779
PMID:35310437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8931769/
Abstract

BACKGROUND: Mounting studies reveal the relationship between inflammatory markers and post-therapy prognosis. Yet, the role of the systemic inflammatory indices in preoperative microvascular invasion (MVI) prediction for hepatocellular carcinoma (HCC) remains unclear. PATIENTS AND METHODS: In this study, data of 1,058 cases of patients with HCC treated in the First Affiliated Hospital of Sun Yat-sen University from February 2002 to May 2018 were collected. Inflammatory factors related to MVI diagnosis in patients with HCC were selected by least absolute shrinkage and selection operator (LASSO) regression analysis and were integrated into an "Inflammatory Score." A prognostic nomogram model was established by combining the inflammatory score and other independent factors determined by multivariate logistic regression analysis. The receiver operating characteristic (ROC) curve and the area under the curve (AUC) were used to evaluate the predictive efficacy of the model. RESULTS: Sixteen inflammatory factors, including neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, etc., were selected by LASSO regression analysis to establish an inflammatory score. Multivariate logistic regression analysis showed that inflammatory score (OR = 2.14, 95% CI: 1.63-2.88, < 0.001), alpha fetoprotein (OR = 2.02, 95% CI: 1.46-2.82, < 0.001), and tumor size (OR = 2.37, 95% CI: 1.70-3.30, < 0.001) were independent factors for MVI. These three factors were then used to establish a nomogram for MVI prediction. The AUC for the training and validation group was 0.72 (95% CI: 0.68-0.76) and 0.72 (95% CI: 0.66-0.78), respectively. CONCLUSION: These findings indicated that the model drawn in this study has a high predictive value which is capable to assist the diagnosis of MVI in patients with HCC.

摘要

背景:越来越多的研究揭示了炎症标志物与治疗后预后之间的关系。然而,全身炎症指标在肝细胞癌(HCC)术前微血管侵犯(MVI)预测中的作用仍不明确。 患者与方法:本研究收集了2002年2月至2018年5月在中山大学附属第一医院接受治疗的1058例HCC患者的数据。通过最小绝对收缩和选择算子(LASSO)回归分析选择与HCC患者MVI诊断相关的炎症因子,并将其整合为“炎症评分”。通过将炎症评分与多因素逻辑回归分析确定的其他独立因素相结合,建立了预后列线图模型。采用受试者操作特征(ROC)曲线和曲线下面积(AUC)评估模型的预测效能。 结果:通过LASSO回归分析选择了16种炎症因子,包括中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值等,以建立炎症评分。多因素逻辑回归分析显示,炎症评分(OR = 2.14,95%CI:1.63 - 2.88,P < 0.001)、甲胎蛋白(OR = 2.02,95%CI:1.46 - 2.82,P < 0.001)和肿瘤大小(OR = 2.37,95%CI:1.70 - 3.30,P < 0.001)是MVI的独立因素。然后利用这三个因素建立了MVI预测列线图。训练组和验证组的AUC分别为0.72(95%CI:0.68 - 0.76)和0.72(95%CI:0.66 - 0.78)。 结论:这些研究结果表明,本研究构建的模型具有较高的预测价值,能够辅助HCC患者MVI的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a51/8931769/9d1982f894b5/fsurg-09-833779-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a51/8931769/a5f54b7653ec/fsurg-09-833779-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a51/8931769/bb7d66aa9971/fsurg-09-833779-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a51/8931769/06a1142ba5e0/fsurg-09-833779-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a51/8931769/9d1982f894b5/fsurg-09-833779-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a51/8931769/a5f54b7653ec/fsurg-09-833779-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a51/8931769/bb7d66aa9971/fsurg-09-833779-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a51/8931769/06a1142ba5e0/fsurg-09-833779-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a51/8931769/9d1982f894b5/fsurg-09-833779-g0004.jpg

相似文献

[1]
Using Systemic Inflammatory Markers to Predict Microvascular Invasion Before Surgery in Patients With Hepatocellular Carcinoma.

Front Surg. 2022-3-4

[2]
Novel Nomogram Based on Inflammatory Markers for the Preoperative Prediction of Microvascular Invasion in Solitary Primary Hepatocellular Carcinoma.

Cancer Manag Res. 2022-3-1

[3]
Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.

BMC Cancer. 2020-2-18

[4]
Radiomic Feature-Based Predictive Model for Microvascular Invasion in Patients With Hepatocellular Carcinoma.

Front Oncol. 2020-11-5

[5]
A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients.

Biomark Res. 2023-10-4

[6]
A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation.

Front Oncol. 2021-3-4

[7]
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.

Ann Transl Med. 2021-3

[8]
Preoperative prediction of microvascular invasion in hepatocellular carcinoma: a radiomic nomogram based on MRI.

Clin Radiol. 2022-4

[9]
Prediction of Microvascular Invasion and Its M2 Classification in Hepatocellular Carcinoma Based on Nomogram Analyses.

Front Oncol. 2022-1-14

[10]
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.

JAMA Surg. 2016-4

引用本文的文献

[1]
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition).

Hepatobiliary Surg Nutr. 2025-4-1

[2]
Development and clinical validation of a novel platelet count-based nomogram for predicting microvascular invasion in HCC.

Sci Rep. 2025-2-18

[3]
A new model based on preoperative AFP, albumin, and tumor burden score for predicting microvascular invasion in early-stage HCC.

Am J Cancer Res. 2024-10-15

[4]
Assessing microvascular invasion in HBV-related hepatocellular carcinoma: an online interactive nomogram integrating inflammatory markers, radiomics, and convolutional neural networks.

Front Oncol. 2024-9-16

[5]
Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database.

Front Oncol. 2022-9-14

本文引用的文献

[1]
Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma.

World J Gastroenterol. 2020-4-14

[2]
A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma.

Liver Cancer. 2019-10

[3]
Nomogram For Preoperative Prediction Of Microvascular Invasion Risk In Hepatocellular Carcinoma.

Cancer Manag Res. 2019-10-22

[4]
A nomogram based on bi-regional radiomics features from multimodal magnetic resonance imaging for preoperative prediction of microvascular invasion in hepatocellular carcinoma.

Quant Imaging Med Surg. 2019-9

[5]
Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: A meta-analysis.

Int J Biol Markers. 2019-9-11

[6]
The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma.

Liver Int. 2019-9-18

[7]
Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.

J Hepatol. 2019-3-13

[8]
Platelet-to-Lymphocyte Ratio and Large Tumor Size Predict Microvascular Invasion after Resection for Hepatocellular Carcinoma.

Asian Pac J Cancer Prev. 2018-12-25

[9]
Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma.

Biosci Rep. 2018-11-13

[10]
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2018-9-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索